Bestandsaufnahme HPV-Impfung

Infektionsschutz erfordert Konsequenz
Dr. med. Michael Wojcinski, Seiten 6-8

  1. Petry KU, Luyten A, Justus A, Iftner A, Strehlke S, Schulze-Rath R et al. Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany. BMC Infect Dis 2012;12:367. Epub 2012/12/25.
  2. Romanowski B, Schwarz TF, Ferguson LM, Peters K, Dionne M, Schulze K et al. Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study. Human vaccines 2011;7(12):1374-86. Epub 2011/11/04.
  3. BGH-Urteil VI ZR 48/99 vom 15. Feb. 2000

Lange Ovarfunktion hat Vorteile

Apoplexrisiko & ovarielle Aktivität
Von Franziska Fauser und Prof. Dr.med. Dipl.-Psych. J. Matthias Wenderlein, Seiten 16-22

  1. Gallagher LG, Davis LB, Ray RM, Psaty BM,Gao DL, Checkoway H, Thomas DB. Reproductivehistory and mortality from cardiovasculardisease amongwomentextileworkersin Shanghai, China.Int J Epidemiol2011 Dec; 40(6):1510-1518.
  2. RoccaWA,GrossardtBR,Miller VM, ShusterLT, Brown RD Jr. Prematuremenopause orearly menopause and risk of ischemic stroke.Menopause 2012Mar; 19(3):272-277.
  3. Baba Y, Ishikawa S, Amagi Y, Kayaba K, GotohT, Kajii E. Prematuremenopause is associatedwith increased risk of cerebral infarctionin Japanese women.Menopause 2010May-Jun; 17(3):506-510.
  4. Yi SW, Odongua N, Nam CM, Sull JW, OhrrH. Body mass index and stroke mortality bysmoking and age atmenopause among Koreanpostmenopausal women. Stroke 2009Nov; 40(11):3428-3435.
  5. Lisabeth LD, Beiser AS, Brown DL,MurabitoJM, Kelly-Hayes M, Wolf PA. Age at naturalmenopause and risk of ischemic stroke: theFramingham heart study. Stroke 2009 Apr;40(4):1044-1049.
  6. de Leciñana MA, Egido JA, Fernández C,Martínez-Vila E, Santos S, Morales A, Martínez E, Pareja A, Alvarez-Sabín J, CasadoI. PIVE Study Investigators of the StrokeProject of the Spanish Cerebrovascular DiseasesStudy Group. Risk of ischemic strokeand lifetime estrogen exposure. Neurology2007 Jan 2; 68(1):33-38.
  7. Cui R, IsoH, ToyoshimaH,DateC, YamamotoA,Kikuchi S,Kondo T,WatanabeY,KoizumiA, Inaba Y, Tamakoshi A. Relationships ofage at menarche and menopause and reproductiveyear with mortality from cardiovascular disease in Japanese postmenopausalwomen: the JACC study. J Epidemiol 2006 Sep; 16(5):177-184.
  8. Jacobsen BK, Heuch I, Kvåle G. Age at naturalmenopause and stroke mortality: cohortstudy with 3.561 strokedeaths during 37years follow up. Stroke 2004 Jul; 35(7):1548-1551.
  9. Jacobsen BK, Oda K, Knutsen SF, Fraser GE.Age at menarche, total mortality and mortalityfrom ischaemic heart disease andstroke:the Adventist Health Study, 1976-88. IntJ Epidemiol 2009 Feb; 38(1):245-252.
  10. Jung SY, Bae HJ, Park BJ, Yoon BW; AcuteBrain Bleeding Analysis Study Group.Parityand risk of hemorrhagic strokes. Neurology2010May 4; 74(18):1424-1429.
  11. Yang L, Kuper H, Sandin S, Margolis KL,Chen Z, Adami HO, Weiderpass E. Reproductivehistory, oral contraceptive use andthe risk of ischemic and hemorrhagic strokein a cohort study of middle-aged Swedishwomen. Stroke 2009 Apr; 40(4):1050-1058.
  12. Qureshi AI, Giles WH, Croft JB, Stern BJ.Number of pregnancies and risk for strokeand stroke subtypes. Arch Neurol. 1997Feb; 54(2):203-206.
  13. Tsuda K, Nishio I. Hyperinsulinemia andestrogen-deficiency as risk factors for strokein women. Stroke 2004 Jun; 35(6):e134;Comment on Stroke 2003Dec;34(12):2812-2816.
  14. Pines A, Bornstein NM, Shapira I. Menopauseand ischaemic stroke: basic, clinicaland epidemiological considerations. The roleof hormone replacement. Hum ReprodUpdate 2002Mar-Apr; 8(2):161-168.
  15. Ingelsson E, Lundholm C, Johansson AL,Altman D. Hysterectomy and risk of cardiovasculardisease: a population-based cohortstudy. EurHeart J 2011Mar; 32(6):745-750.
  16. Carswell HV,Macrae IM, Farr TD. Complexitiesof oestrogen in stroke.ClinSci (Lond)2009 Dec 15; 118(6):375-389.
  17. Parker WH, Broder MS, Liu Z, Shoupe D,Farquhar C, Berek JS. Ovarian conservationat the time of hysterectomy for benign disease.Obstet Gynecol. 2005 Aug;106(2):219-226.
  18. Rossberg MI, Murphy SJ, Traystman RJ,Hurn PD. LY353381.HCl, a selective estrogenreceptor modulator and experimentalstroke. Stroke 2000 Dec; 31(12):3041-3046.
  19. Dubal DB, Kashon ML, Pettigrew LC, RenJM, Finklestein SP, Rau SW, Wise PM. Estradiolprotects against ischemic injury. J CerebBlood Flow Metab 1998 Nov; 18(11):1253-1258.
  20. Solomon CG, Hu FB, Dunaif A, Rich-EdwardsJE, Stampfer MJ,WillettWC, SpeizerFE, Manson JE. Menstrual cycle irregularityand risk for future cardiovascular disease. JClinEndocrinolMetab 2002 May;87(5):2013-2017.
  21. Irioka T, Mizusawa H. Ischemic stroke in ayoung adult with Turner syndrome. NeurolSci. 2011 Apr; 32(2):317-319.
  22. Terasaki T, Hashimoto Y,Miyashita F, KozakiY, Naganuma M, Uchino M, Mabe H. Acase of Turner syndrome complicated withbrain infarction. RinshoShinkeigaku 2002Feb; 42(2):145-148. (Artikel: japanisch)
  23. Miyamoto T, Tarukawa Y, Katayama S, SatoM, Shimizu S, Homma M, Watanabe K, Miyamoto M, Hirata K. Cerebral infarctiondue to stenosis of the bilateral internal carotid artery in Turners syndrome. No ToShinkei 1997 Oct; 49(10):919-923. (Artikel: japanisch)

Pathophysiologie und therapeutische Optionen

Dysmenorrhö bei jungen Mädchen
von Dr. med. Julia Bartley, Seiten 25 bis 32

  1. Ambresin A, Belanger RE,Chamay C, Bertold A, Narring F. Body dissatisfaction on top of depressive mood among adolescents with severe dysmenorrhoea. J PediatrAdolescGynecol 2012; 25: 19-22.
  2. Andersch B, Milsom I.An epidemiological study of young women withdysmenorrhoea.Am J ObstetGynecol 1982; 144: 655-660.
  3. Batt RE, Mitwally MFM. Endometriosis from thelarche to midteens: pathogenesis and prognosis, prevention and pedagogy. J PediatrAdolescGynecol 2003; 16: 337-347.
  4. Balbi C, Musone R, De Franciscis P. Influence of menstrual factors and dietary habits on menstrual pain in adolescent females. J PediatrAdolescGynecol 2000; 19: 271-275.
  5. Biberoglu KO; Behrman SJ. Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness. Am J ObstetGynecol 1981; 139(6): 645-54.
  6. Creatsas GE, Deligeooglou E, ZachariA et al. Prostaglandins: PGF2?, PGE2, 6-keto-PGI ? and TGB serum levels in dysmenorrhoeic adolescents before, during and after treatmant with oral contraceptives. Eur J ObstetGynecolReprodBiol 1990; 36: 292-298.
  7. Gille G, Layer C, Hinzpeter B. Identität im Fluss - Menstruationserleben junger Mädchen. Gynäkologe 2010; 1: 1-8.
  8. Goldenstein DP, DeCholnoky C, Emans SJ.Adolescent endometriosis.J Adol Health Care 1980; 1: 37-41.
  9. Greil H, Kahl H. Assessment of developmental age: cross-sectional analysis of secondary sexual characteristics. AnthropolAnz. 2005; 63(1): 63-75.
  10. Harel Z. Dysmenorrhea in Adolescents. Ann NY AcadSci 2008; 1135: 185-195.
  11. Harlow SD, Campell OM. Epidemiology of menstrual disorders in developing countries: a systematic review. BJOG 2004; 111: 6-16.
  12. Hillen TIJ, Grbavac SL, Johnston PJ, Straton JAY, Keogh JMF.Primary dysmenorrhoea in young western Australian women: prevalence, impact, and knowledge of treatment. J Adolesc Health 1999; 25: 40-45.
  13. Hornsby PP, Wilcox CR, Weinber CR. Cigarette smoking and disturbance of menstrual function. Epidemiology 1998; 9: 193-198.
  14. Hudelist G, Fritzer N, Thomas A, Niehuies C, Oppelt P, Haas D, Tammaa A, Salzter H. Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod 2012; 27(12):3412-3416.
  15. Klein JR, Litt LF. Epidemiology of adolescent dysmenorrhoea.Pediatrics 1981; 68: 661-664.
  16. Laufer MR, Goitein L, Bush M, Cramer DW, Emans SJ. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J PediardAdolescGyencol 1997; 10(4): 199-202.
  17. Lundstrom V, Green K. Endogenous levels of prostaglandin F2? and its main metabolites in plasma and endometrium of normal and dysmenorrhoeic women. Am J ObstetGynecol 1978; 130: 640-646.
  18. Marjoribanks J, Proctor M, Farquhar C, Derks RS. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea, Cochrane Database 2010; 1 Art No.: CD001751.
  19. Nappi C, Bifulco G, Tommaselli GA, Gargano V, Di Carlo C. Hormonal contraception and bone metabolism: a systematic review. Contraception 2012; 86(6): 606-21.
  20. O´Conell K, Davis AR, Westhoff C. Selftreatment patterns among adolescent girls with dysmenorrhoea. J PediatrAdolescGynecol 2006; 19: 285-289.
  21. Rees MCP, Anderson ABM, Demers M et al. Prostaglandins in menstrual fluid in menorrhoagia and dysmenorrhoea. Br J ObstetGynecol 1978; 91: 673-680.
  22. Rees MCP, DI Marzo JR, Tippins JR. Leukotriens release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia. J Endocrinol 1987; 113: 291-295.
  23. Reese KA, Reddy S, Rock JA. Endometriosis in the adolescent population: the Emory experience. J PediatrAdolescGynecol 1996; 9: 125-128.
  24. Roman JD. Adolescent endometriosis in the Waikato region of New Zealand – a comparative cohort study with a mean follow-up time of 2.6 years.Aust N Z J ObstetGynaecol 2010; 50: 179-183.
  25. Sabatini R, Orsini G, Cagiano R, Loverro G. Noncontraceptive benefits of two combined oral contraceptives with antiandrogenic properties among adolescents. Contraception 2007; 76: 342-347.
  26. Schramm G, Heckes B. Switching hormonal contraceptives to a chlormadinon acetate-containing oral contraceptive. The contraception switch study. Contraception 2007; 76: 84-90.
  27. Solnik MJ.Chronic pelvic pain and endometriosis in adolescents.CurrOpinObstetGynecol 2006; 18: 511-518.
  28. Stravoulis AI, Saridogan E, Creighton SM, Cutner AS. Laparoscopic treatment of endometriosis in teenagers.Eur J ObstetGynecol 2005; 125: 248-250.
  29. Ugur M, Turan C, Mugan T et al. Endometriosis is associated with müllerian anomalies. GynecolObstetInvest 1995; 40: 261-264.
  30. Zahradnik HP, Wetzka B, Schuth W. ZyklusanhängigeBefindlichkeitsstörungen der Frau. Gynäkologe 2000; 33: 225-238.
  31. Zahradnik HP, Hanjalic-Beck A, Groth. Nonsteroidal anti-inflammatory drugs and hormonal contraceptives for pain relief from dysmenorrhoea: a review. Contraception 2010; 81: 185-196.

Das Archimetraprinzip (Teil 1)

Neue Erkenntnisse zur Pathophysiologie von Endometriose und Adenomyose
von Prof. Dr. med. Gerhard Leyendecker und Prof. Dr. med. Ludwig Wildt, Seiten 34-42

  1. Leyendecker G, Wildt L A new concept of endometriosis and adenomyosis: tissue injury and repair. HormMolBiolClin Invest 2011; 5(2): 125 -142.
  2. Sampson JA. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity.Am J ObstetGynecol 1927;14:422-469.
  3. Cullen TS. The distribution of adenomyoma containing uterine mucosa.Arch Surgery 1920;1:215-83.
  4. Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis.Tissue injury and repair. Arch. GynecolObstet 2009;280:529-538.
  5. Leyendecker G, Kunz G, Noe M, Herbertz M and Mall G. Endometriosis: A dysfunction and disease of the archimetra. Hum Reprod Update 1998;4:752-762.
  6. Aghajanova L, Hamilton A, Kwintkiewicz J, Vo KC, Giudice LC. Steroidogenic enzyme and key decidualization marker dysregulation in endometrial stromal cells from women with versus without endometriosis. BiolReprod 2009; 80:105-114.
  7. Bulun SE. Endometriosis. N Engl J Med 2009; 360:268-279.
  8. Emge LA. The elusive adenomyosis of the uterus.Its historical past and its present state of recognition. Am J Obstet Gynecol 1962; 83: 1541-1563.
  9. Kunz G, Beil D, Huppert P, Noe M, Kissler S, &Leyendecker G. Adenomyosis in endometriosis – prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod2005; 20: 2309-2316.
  10. Kunz G, Beil D, Deininger H, Wildt L, Leyendecker G The dynamics of rapid sperm transport through the female genital tract. Evidence from vaginal sonography of uterine peristalsis (VSUP) and hysterosalpingoscintigraphy (HSSG). Hum. Reprod. 1996;11:627-632.
  11. Wildt L, Kissler S, Licht P, Becker W. Sperm transport in the human female genital tract and its modulation by oxytocin as assessed by hysterosalpingography, hysterotonography, electrohysterography and Doppler sonography. Hum Reprod Update 1998;4:655-666.
  12. Garcia-Segura LM. Aromatase in the brain: not just for reproduction anymore. J Neuroendocrinol 2008; 20:705-712.
  13. Leyendecker G, Kunz G, Wildt, L, Beil, D, Deiniger H. Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endometriosis and infertility. Hum Reprod 1996; 11: 1542-1551.
  14. Absenger Y, Hess-Stumpp H, Kreft B, Kratzschmar J, Haendler B, Schutze N, Regidor PA, Winterhager E. Cyr61, a deregulatedgene in endometriosis. Mol Hum Reprod. 2004;10:399-407.
  15. Gashaw I, Hastings JM, Jackson KS, Winterhager E, Fazleabas AT. Induced endometriosis in the baboon (Papioanubis) increases the expression of the proangiogenic factor CYR61 (CCN1) in eutopic and ectopic endometria. BiolReprod 2006; 74: 1060-1066.
  16. Yang G, Im HJ, Wang JH. Repetitive mechanical stretching modulates IL-1beta induced COX-2, MMP-1 expression, and PGE2 production in human patellar tendon fibroblasts. Gene 2005;363:166-172.
  17. Bokor A, Debrock S, Drijkoningen M, Goossens W, Fülöp V, D'Hooghe T.
    Quantity and quality of retrograde menstruation: a case control study. ReprodBiolEndocrinol2009;7:123-130.
  18. Osteen KG, Yeaman GR, Bruner-Tran KL. Matrix metalloproteinases and endometriosis.SeminReprod Med 2003;21:155-164.
  19. Bartosik D, Jakobs SL, Kelly LJ.Endometrial tissue in peritoneal fluid.FertilSteril 1986; 46: 796-800.
  20. Simon C, Gutierrez A, Vidal A, de los Santos MJ, Tarin JJ, Remohi J and Pellicer A. Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod 1994;9:725-29.
  21. Bulun SE, Cheng YH, Pavone ME, Yin P, Imir G, Utsunomiya H, Thung S, Xue Q, Marsh EE, Tokunaga H, Ishikawa H, Kurita T, Su EJ. 17Beta-hydroxysteroid dehydrogenase-2 deficiency and progesterone resistance in endometriosis.SeminReprod Med 2010;28:44-50.
  22. Mechsner S, Kaiser A, Kopf A, Gericke C, Ebert A, Bartley J. A pilot study to evaluate the clinical relevance of endometriosis-associated nerve fibers in peritoneal endometriotic lesions.FertilSteril 2009;92:1856-1861.
  23. Nguyen LP, Bradfield CA.The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 2008;21:102-16.
  24. Guo SW, Simsa P, Kyama CM, Mihályi A, Fülöp V, Othman EE, D'Hooghe TM. Reassessing the evidence for the link between dioxin and endometriosis: from molecular biology to clinical epidemiology.Mol Hum Reprod 2009;15:609-624.
  25. Conway DE, Sakurai Y, Weiss D, Vega JD, Taylor WR, Jo H, Eskin SG, Marcus CB, McIntire LV. Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress. Cardiovasc Res 2009;81:669-677.
  26. Meyer RM, Barton M. ER?, ERß, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis. Cardiovasc Res 2009; 83: 605-610.

Operative Therapie des Mammakarzinoms

Erfahrungen und Chancen in der Ultraschallchirurgie
von Dr.med. Franz von Koch, Seiten 44-46

  1. Böhm D, Kubitza A, Lebrecht A, Schmidt M, Gerhold-Ay A, Battista M, Stewen K, Solbach C, Kölbl H. Prospective randomized comparison of conventional instruments and the Harmonic Focus® devioce in breast-conserving therapy for primary breast cancer. Eur J. Surg. Oncol. 2012 Feb. 38 (2): 118-24  doi: 10.10(16), ejso2011.11.003. Epub 2011 Dec 5.
  2. Sanguinetti A., Docimo G., Ragusa M. , Calzolai F. , D’Ajelo F., Ruggiero R., Parmeggiani D., Pezzola A., Procaccino E., Averia N. Ultrasound scissors versus electrocautery in axillary dissection: our experience. G Chir. 2010 Apr, 31(4); 151-153.
  3. He Q., Zhuang D. Zheng L., Fan Z. Zhou P., Zhu J. LvZ Chai J. Cao L.Harmonic focus versus electrocautery in axillary lymph node dissection for breast cancer: a randomized clinical study. Clin Breast Cancer 2012 Dec. 12(6); 454-458. doi. 10.16/cibc.2012.07.014 Epub 2012 Oct.
  4. Iovino F, Auriemma P, Ferracaccio F, Antoniol G, Barbarisi A. Preventing seroma formation after axillary dissection for breast cancer: a randomized clinical trial. Am J Surg. 2012; 6 203(6): 708-14.doi. 10.1016/j.amjsurg. 2011.06.051 Epub 2011 Dec 6.
  5. Sanguinetti A, Docimo G, Ragusa M, Calzolai F, D’Ajello F, Ruggiero R, Parmeggian D, Pezzola A, Procaccino E, Avenia N. Ultrasound scissors versus elektrocautery in axillary dissection: our experience.G Chir2010; 4 Vol.31-n.4-pp. 151-153.
  6. Deo SV, Strukla NK, Asthana S, Niranian B, Srinivas G. A comparative study of modified radical mastectomy using harmonic scalpel and electrocautery.Singapore Med J. 2002; 43(5); 226-228.
  7. Kozomara D, Galic G, Brekalo Z, Sutalo N, Kvestic A, Solic M. A randomized two-way comparison of mactectomy performed using harmonic scalpel or monopolar diathermy. CollAntropol 2010; 3, 34 Suppl. 1: 105-112.
  8. Yilmaz KB, Dogan L, Nalbart H, Akinci M, Karaman N, Ozaslan C, Kulacoglu H.Comparing scalpel, electrocautery and ultrasonic dissector effects: the impact on wound complications and pro-inflammatory cytokine levels in wound fluid from mastectomy patients. J Breast Cancer 2011 Mar. 14(1); 58-63.
  9. Currie A, Chong K, Davies GL, Cummins RS. Ultrasonic dissection versus electrocautery in mastectomy for breast cancer - a meta-analysis.Eur J SurgOncol 2012; Oct. 38(10) 897-901.
  10. Ceccaldi PF, Ducarme G,Kéré D, Wernert R.Effect of ultrasonic energy dissection technique in breast reconstruction with the autologous latissimusdorsi flap. J GynecolObstetBiolReprod (Paris) 2006 Dec; 35(8 PT 1): 762-766.
  11. Burdette TE, Kerrigan CL, Homa K. Harmonic scalpel versus electrocautery in breast reduction surgery: a randomized controlled trial. Plast Reconstr Surg 2011 Oct. 128(4): 243e-249e
  12. Ribeiro GH, Kerr LM, Haikel RL, Peres SV, Matthes AG, DepieriMichelli RA, Balao A Jr, Fregnani H, Vieira RA. Modified radical mastectomy: A pilot clinical trial comparing the use of conventional electric scalpel and harmonic scalpel.Int J Surg. 2013; 11(6): 496-500.
  13. Poole G, Bigger M, Moss D.Use of the harmonic scalpel for breast surgery in patients with a cardiac pacemaker - a tip.Breast J. 2010, Jan.-Feb. 16(1), 108.8, doi.10.1111j, 1524-4741.2009.00854 x. Epub 2009 Nov 24.